The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods

Virology Journal

Volumn 8, Issue , 2011, Pages

  Kim, Hyunil ^a,b   Kim, Hye Kwon ^b   Jung, Jung Ho ^a   Choi, Yoo Jung ^a   Kim, Jiho ^a   Um, Chang Gyu ^a   Hyun, Su Bin ^a   Shin, Sungho ^a   Lee, Byeongchun ^b   Jang, Goo ^b   Kang, Bo Kyu ^c   Moon, Hyoung Joon ^c   Song, Dae Sub ^d  

^a Optifarm Solution Inc   (South Korea)

^b Seoul National University   (South Korea)

^c Green Cross Veterinary Products   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; IMMUNOGLOBULIN G; INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE; INACTIVATED VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; VIREMIA; ANIMAL; ARTERIVIRUS; BLOOD; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; SERODIAGNOSIS; SWINE; VIRUS LOAD;

PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; NEUTRALIZATION TESTS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; VACCINES, INACTIVATED; VIRAL LOAD; VIRAL VACCINES; VIREMIA;

EID: 79959534361     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-323     Document Type: Article

References (30)

1. Reproductive failure of unknown etiology. KK Keffaber, Am Assoc Swine Prac Newsl 1989 1 1 10
2. Mystery swine disease in The Netherlands: the isolation of Lelystad virus. G Wensvoort C Terpstra JM Pol EA ter Laak M Bloemraad EP de Kluyver C Kragten L van Buiten A den Besten F Wagenaar,, et al. Vet Q 1991 13 121 130 1835211
3. Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). DA Benfield E Nelson JE Collins L Harris SM Goyal D Robison WT Christianson RB Morrison D Gorcyca D Chladek, J Vet Diagn Invest 1992 4 127 133 10.1177/104063879200400202 1616976
4. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. D Cavanagh, Arch Virol 1997 142 629 633 9349308
5. Experimental reproduction of swine infertility and respiratory syndrome in pregnant sows. WT Christianson JE Collins DA Benfield L Harris DE Gorcyca DW Chladek RB Morrison HS Joo, Am J Vet Res 1992 53 485 488 1586017
6. A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions. G Nodelijk MC de Jong LA van Leengoed G Wensvoort JM Pol PJ Steverink JH Verheijden, Vaccine 2001 19 3636 3644 10.1016/S0264-410X(01)00099-8 11395197 (Pubitemid 32522761)
7. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. EJ Neumann JB Kliebenstein CD Johnson JW Mabry EJ Bush AH Seitzinger AL Green JJ Zimmerman, J Am Vet Med Assoc 2005 227 385 392 10.2460/javma.2005.227.385 16121604 (Pubitemid 41098522)
8. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. FA Zuckermann EA Garcia ID Luque J Christopher-Hennings A Doster M Brito F Osorio, Vet Microbiol 2007 123 69 85 10.1016/j.vetmic.2007.02.009 17376612 (Pubitemid 46898707)
9. Preliminary assessment of an inactivated PRRS virus vaccine on the excretion of virus in semen. SL Swenson HT Hill JJ Zimmerman LE Evans RW Wills KJ Yoon KJ Schwartz GC Althouse MJ McGinley AK Brevik, Swine Health and Production 1995 3 244 247
10. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity. P Martelli S Gozio L Ferrari S Rosina E De Angelis C Quintavalla E Bottarelli P Borghetti, Vaccine 2009 27 3788 3799 10.1016/j.vaccine.2009.03.028 19442420
11. Examination of virus shedding in semen from vaccinated and from previously infected boars after experimental challenge with porcine reproductive and respiratory syndrome virus. TL Nielsen J Nielsen P Have P Baekbo R Hoff-Jorgensen A Botner, Vet Microbiol 1997 54 101 112 10.1016/S0378-1135(96) 01272-2 9057254 (Pubitemid 27110072)
12. Efficacy of an inactivated vaccine for prevention of reproductive failure induced by porcine reproductive and respiratory syndrome virus. J Plana-Duran M Bastons A Urniza M Vayreda X Vila H Mane, Vet Microbiol 1997 55 361 370 10.1016/S0378-1135(96)01317-X 9220634 (Pubitemid 27286233)
13. Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein. P Gonin B Pirzadeh CA Gagnon S Dea, J Vet Diagn Invest 1999 11 20 26 10.1177/104063879901100103 9925207 (Pubitemid 129693006)
14. PRRS virus serum neutralization antibody as a measure of protection. HS Joo K Direksin C Johnson W Lee N Debuse, Leman Swine Conference; Minneapoli, MN, Allen D, 1999 183 186
15. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. FA Osorio JA Galeota E Nelson B Brodersen A Doster R Wills F Zuckermann WW Laegreid, Virology 2002 302 9 20 10.1006/viro.2002.1612 12429512 (Pubitemid 35356851)
16. Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs. GG Labarque HJ Nauwynck K Van Reeth MB Pensaert, J Gen Virol 2000 81 1327 1334 10769076 (Pubitemid 30232719)
17. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs. D Nilubol KB Platt PG Halbur M Torremorell DL Harris, Vet Microbiol 2004 102 11 18 10.1016/j.vetmic.2004.05.006 15288922 (Pubitemid 39037369)
18. Efficacy of an inactivated PRRSV vaccine: induction of virus-neutralizing antibodies and partial virological protection upon challenge. G Misinzo PL Delputte P Meerts C Drexler HJ Nauwynck, Adv Exp Med Biol 2006 581 449 454 10.1007/978-0-387-33012-9-81 17037577
19. Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV. M Scortti C Prieto E Alvarez I Simarro JM Castro, Vet Rec 2007 161 809 813 18083979
20. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows. VG Papatsiros C Alexopoulos SK Kritas G Koptopoulos HJ Nauwynck MB Pensaert SC Kyriakis, J Vet Med B Infect Dis Vet Public Health 2006 53 266 272 16907957 (Pubitemid 44127867)
21. The porcine reproductive and respiratory syndrome quandary. Part II: Vaccines and vaccination strategy. WL Mengeling, Journal of Swine Health and Production 2005 152 156 (Pubitemid 40707799)
22. Vaccination with porcine reproductive and respiratory syndrome killed virus vaccine and immunostimulatory oligodeoxynucleotides induces specific immunity in piglets. Z Linghua T Xingshan Z Fengzhen, Vaccine 2007 25 1735 1742 10.1016/j.vaccine.2006.11.033 17229497 (Pubitemid 46195164)
23. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. HG Bahnemann, Vaccine 1990 8 299 303 10.1016/0264-410X(90)90083-X 2204242 (Pubitemid 20264802)
24. Inactivation of African horse-sickness virus by betapropiolactone and by pH. J Parker, Arch Virol 1975 47 357 365 10.1007/BF01347977 237497
25. Seroprevalence of antibody to procine reproductive and respiratory syndrome virus in diagnostic submissions. SM Kim TU Han SY Kang KS Shin CJ Kim JT Kim HS Kim, J Vet Sci 2002 3 159 161 12514325
26. Genetic analysis of ORF5 of recent Korean porcine reproductive and respiratory syndrome viruses (PRRSVs) in viremic sera collected from MLV-vaccinating or non-vaccinating farms. HK Kim JS Yang HJ Moon SJ Park Y Luo CS Lee DS Song BK Kang SK Ann CH Jun BK Park, J Vet Sci 2009 10 121 130 10.4142/jvs.2009.10.2.121 19461207
27. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine. S Suradhat S Kesdangsakonwut W Sada S Buranapraditkun S Wongsawang R Thanawongnuwech, Vaccine 2006 24 2634 2642 10.1016/j.vaccine.2005.12.010 16406169 (Pubitemid 43290395)
28. Assessing the functionality of viral entry-associated domains of porcine reproductive and respiratory syndrome virus during inactivation procedures, a potential tool to optimize inactivated vaccines. I Delrue PL Delputte HJ Nauwynck, Vet Res 2009 40 62 10.1051/vetres/2009047 19674538
29. Inactivation of infectious bursal disease virus by binary ethylenimine and formalin. M Habib I Hussain WH Fang ZI Rajput ZZ Yang H Irshad, J Zhejiang Univ Sci B 2006 7 320 323 16532536
30. Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies. M Vanhee PL Delputte I Delrue MF Geldhof HJ Nauwynck, Vet Res 2009 40 63 10.1051/vetres/2009046 19674539